CME — CME Group Inc.
Is CME overbought or oversold? Here is the current MarketMoodz read.
CME Group Inc. (CME) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of October 3, 2026. The Financial Services name (Financial Data & Stock Exchanges) last closed at $263.14. The rating moved from Neutral to Oversold on October 2, 2026.
- Public ratingOversold (as of October 3, 2026)
- Last close$263.14
- Last changeMoved from Neutral to Oversold on October 2, 2026
- SectorFinancial Services
- IndustryFinancial Data & Stock Exchanges
See all oversold Financial Services stocks →
AI analysis
CME Group Inc. (CME) benefits from a durable, high-margin derivatives and clearing franchise with recurring fee streams and strong market share across major asset classes. Recent market caution and geopolitical headlines can increase hedging activity, supporting volumes in the near term, while structural tailwinds (e.g., broader custodial flows) and disciplined capital returns underpin upside. Primary vulnerabilities are sensitivity to sustained low volatility, regulatory/clearing operational risks, and competition from evolving trading models.
Key factors
- High-quality derivatives and clearing franchise with recurring transaction and clearing fees that support resilient cash flow and margins for CME Group Inc. (CME).
- Market-share leadership across futures and options on interest rates, FX, and equity indices, providing structural advantages and pricing power.
- Sensitivity to volatility and notional traded volumes—periods of elevated market uncertainty tend to boost ADV and revenue; recent risk-off tone could increase client hedging activity.
- Favorable secular flows: Treasury auto-enrollment and potential increase in custody/ETF flows support trading and hedging demand across listed products and derivatives.
- Strong capital return profile (dividends and buybacks) and conservative balance sheet strengthen investor appeal and downside support.
- Technology-driven product launches and high switching costs for clearing participants sustain long-term competitive moat and operating leverage.
Risks
- Trading volume sensitivity: prolonged low volatility or weak macro activity could materially reduce ADV and fee revenue.
- Regulatory and policy risk around clearinghouse practices, margin requirements and potential new rules affecting market structure or product offerings.
- Concentration risk: large declines in rates- or equity-linked derivative flows could disproportionally impact short-term results.
- Operational/clearing risk: a major clearing failure, cyber event, or infrastructure outage would have outsized financial and reputational consequences.
- Competition from alternative trading venues, OTC platforms, or new fintech tokenized markets that could disintermediate some listed volumes over time.
- Geopolitical shocks and macro shifts (e.g., rapid Fed policy moves or liquidity stress in credit markets) that change client behavior unpredictably.
Latest MarketMoodz coverage
- 4% CD Yields Reappear — Practical Guide for Income Investors2026-06-30
- ICE, CME Among Most Oversold Stocks; Rebound Ahead?2026-06-27
- KBW: Buy the Dip in CME Group — Perpetual Fears Overblown2026-06-18
- CME to Sue CFTC Over Perpetual Futures, Duffy Says2026-06-17
- Terry Duffy to Step Down as CME CEO; Lynne Fitzpatrick to Succeed2026-06-17
See today's live rating, score and targets
Members see the live hourly rating for CME — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.